Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway. [electronic resource]
Producer: 20150929Description: 250-6 p. digitalISSN:- 1980-5322
- Abietanes -- pharmacology
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Blotting, Far-Western
- Cell Migration Assays
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured -- drug effects
- Collagen Type I -- analysis
- Collagen Type III -- analysis
- Enzyme Activation -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- drug effects
- Female
- Fluorescent Antibody Technique
- Humans
- Interleukin-17 -- analysis
- Male
- Middle Aged
- Muscle, Smooth, Vascular -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Reproducibility of Results
- Salvia miltiorrhiza -- chemistry
- Scleroderma, Systemic -- drug therapy
- Statistics, Nonparametric
- Time Factors
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.